100 likes | 285 Views
Next Steps: Implementation Workshop on Standards for Systematic Reviews and Clinical Practice Guidelines. Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies. Council of Medical Specialty Societies. 37 Member Specialty Societies
E N D
Next Steps: Implementation Workshop on Standards for Systematic Reviews and Clinical Practice Guidelines Institute of Medicine May 11, 2011 Norman Kahn MD Council of Medical Specialty Societies
Council of Medical Specialty Societies • 37 Member Specialty Societies • 700,000 physicians in the US • Strategic Priorities: • Facilitate a Culture of Performance Improvement in Practice • Model Professionalism • Altruism (putting patients’ needs first) • Self-regulation • Transparency (to peers, patient, the public)
CMSS Code for Interactions with Companies • Adopted April 2010, revised March 2011 • 34 signers to date • Independence and transparency • CPG’s • Professional responsibility of specialty societies to develop practice guidelines • Evidence-based • Independent, transparent development process • No company financial support • Disclosure, management and resolution of relationships resulting in perceived conflicts of interest • Chair and majority of panel free of relationships • Rigorous internal and external review
CMSS Draft Recommendations for the Development of Trustworthy Clinical Practice Guidelines • Conflict of Interest • Transparency • Disclosure of relevant relationships • Resolution of conflicts of interest • Chair plus majority of writing panel with no relationships (CMSS Code for Interactions with Companies, 2010, revised 2011)
CMSS Draft Recommendations – CPG’s • Comprehensive systematic evidence reviews • Assessment of the strength of evidence • Recommendations should be actionable • Clear, direct guidance • Recommendations should be practical • Focus on high level evidence
CMSS Draft Recommendations – CPG’s • Developer qualifications • Methodologist • Librarian • Multi-disciplinary panel • Panel training • External review • Patient preferences and feedback
CMSS Draft Recommendations – CPG’s • Development process • Purpose/rationale/clinical question for the guideline • Evidence-grading system disclosed • Reconciling low quality evidence • Timeline, maintenance and expiration • Performance metrics for implementation
CMSS Draft Recommendations – CPG’s • Scope • Intended audience • Patient population • Distribution • Web • National Guidelines Clearinghouse
CMSS Draft Recommendations – CPG’s • Funding • No industry support for guideline development (CMSS Code) • Derivative products
Next Steps • Internal CMSS review • External review and feedback • CMSS Council November 19, 2011